Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 -0.01 (-1.57%)
As of: Oct 22, 2026 · 3:59 PM EDT

Jasper Therapeutics (JSPR) Return on Capital Employed [ROCE] (2020 - 2025)

Updated

Jasper Therapeutics (JSPR) posted Return on Capital Employed [ROCE] of -250.97% for Q4 2025, down 148.52 percentage points from -102.45% a year earlier but up 50.81 percentage points from the prior quarter.

Analysis

Jasper Therapeutics (JSPR) Return on Capital Employed [ROCE] (2020 - 2025) Analysis & Trends

For FY2025, Jasper Therapeutics' Return on Capital Employed [ROCE] came in at -187.91%, down 82.26 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -152.57 percentage points (FY2020 to FY2025).
  • In prior years, Jasper Therapeutics' Return on Capital Employed [ROCE] was -105.65% in FY2024 (+10.56 pp), -116.22% in FY2023 (-36.15 pp), -80.07% in FY2022 (-7.11 pp) and -72.96% in FY2021 (-37.61 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -301.78% in Q3 2025 to a high of -26.53% in Q2 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last eight quarters, with an average year-over-year change of -93.95 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2023, with a gain of 33.42 percentage points; the weakest was Q2 2025, with a drop of 236.25 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -301.78% (Q3 2025), -298.28% (Q2 2025) and -147.07% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 17.52%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 17.92%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.28%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.76%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 11.86%
10 Jasper Therapeutics 14.21 Mn -112.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -250.97%
Sep 30, 2025 -301.78%
Jun 30, 2025 -298.28%
Mar 31, 2025 -147.07%
Dec 31, 2024 -102.45%
Sep 30, 2024 -72.90%
Jun 30, 2024 -62.03%
Mar 31, 2024 -68.94%
Dec 31, 2023 -76.28%
Sep 30, 2023 -61.57%
Jun 30, 2023 -47.54%
Mar 31, 2023 -61.13%
Dec 31, 2022 -109.70%
Sep 30, 2022 -86.42%
Jun 30, 2022 -68.14%
Mar 31, 2022 -53.44%
Dec 31, 2021 -39.86%
Sep 30, 2021 -32.42%
Jun 30, 2021 -26.53%
Mar 31, 2021 -29.93%
API Access

Jasper Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=JSPR&period=max&api_key=YOUR_API_KEY